NCT03829293View on ClinicalTrials.gov

High-Flow Nasal Oxygenation Versus Standard Oxygenation in Gastrointestinal Endoscopy With Sedation.

NACompletedINTERVENTIONAL

Enrollment

380

Participants

Timeline

Start Date

March 26, 2019

Primary Completion Date

September 9, 2019

Study Completion Date

September 9, 2019

Conditions

Gastrointestinal EndoscopySedation

Interventions

DEVICE

High-flow nasal cannula oxygenation group

usual care + High-flow nasal oxygenation (HFNO) therapy during GI endoscopy under sedation (with a flow at 70L/min and FiO2 50%) through a dedicated system, the THRIVETM (Fisher\&Paykel, New-Zealand)

Trial Locations (3)

45000

Pole santé ORELIANCE, Orléans

45067

Orleans Hospital Center, Orléans

Unknown

Hospital Center of DAX, Dax

All Listed Sponsors

lead

Centre Hospitalier Régional d'Orléans

OTHER

NCT03829293 - High-Flow Nasal Oxygenation Versus Standard Oxygenation in Gastrointestinal Endoscopy With Sedation. | Biotech Hunter | Biotech Hunter